Widespread expression of parathyroid hormone-related peptide in melanocytic cells

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 533-538

  Kageshita, Toshiro ^a   Ishihara, T ^a   Tokuo, H ^a   Funasaka, Y ^b   Ichihashi, M ^b   Dong, J ^c   Nakajima, M ^c   Ono, T ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NOVARTIS PHARMA K K   (Japan)

Author keywords

Disease progression; Malignant melanoma; Parathyroid hormone related peptide

Indexed keywords

MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL LINE; CELL LYSATE; CELL SECRETION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNORADIOMETRIC ASSAY; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SKIN DEFECT; SUPERNATANT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; NEVUS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HORMONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037362524     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05171.x     Document Type: Article

References (30)

1. Rosol TJ, Capen CC. Mechanisms of cancer-induced hypercalcemia. Lab Invest 1992; 67: 680-702.
2. Strewler GJ. The parathyroid hormone-related protein. Endocrinol Metab Clinics North Am 2000; 29: 629-45.
3. Matsui T, Kageshita T, Ishihara T et al. Hypercalcemia in a patients with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein. Dermatology 1998; 197: 65-8.
4. Kageshita T, Matsui T, Hirai S et al. Hypercalcemia in melanoma patients associated with increased levels of parathyroid hormone-related protein. Melanoma Res 1999; 9: 69-73.
5. Yeung SC, Eton O, Burton DW et al. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma. Horm Res 1998; 49: 288-91.
6. Elias AN, Pandian MR, Jacowatz J. Parathyroid hormone-related protein in patients with malignant melanoma. Arch Dermatol 1992; 128: 278-9.
7. El Abdaimi K, Papavasiliou V, Goltzman D, Kremer R. Expression and regulation of parathyroid hormone-related peptide in normal and malignant melanocytes. Am J Cell Physiol 2000; 279: C1230-38.
8. Danks JA. Ebeling PR, Hayman J et al. Parathyroid hormone-related protein. Immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 1989; 4: 273-8.
9. Halaban R, Gosh S, Duray P et al. Human melanocytes cultured from nevi and melanomas. J Invest Dermatol 1986; 87: 95-101.
10. Funasaka Y, Boulton T, Cobb M et al. C-kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanoma. Mol Biol Cell 1992; 3: 197-209.
11. Ohashi A, Funasaka Y, Ueda M, Ichihashi M. c-Kit receptor expression in cutaneous melanoma and benign melanocytic nevi. Melanoma Res 1996; 6: 25-30.
12. Byers HR, Etoh T, Doherty JR et al. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol 1991; 139: 423-35.
13. Beahrs OH. Henson DE, Hutter RVP, Kennedy BJ, eds. Malignant melanoma of the skin. In: Manual for Staging of Cancer: American Joint Committee on Cancer, 4th edn. Philadelphia: JB Lippincott, 1992: 143-8.
14. Kageshita T, Funasaka Y, Ichihashi M et al. Tissue factor expression and serum level in patients with melanoma does not correlate with disease progression. Pigment Cell Res 2001; 14: 195-200.
15. Berchuck A, Soisson AP, Clarke-Pearson DL et al. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Cancer Res 1989; 49: 2091-5.
16. Nishihara M, Ito M, Tomooka T et al. Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumors. J Pathol 1999; 187: 217-22.
17. Yoshida A, Nakamura Y, Shimizu A et al. Significance of the parathyroid hormone-related protein expression in breast carcinoma. Breast Cancer 2000; 7: 215-20.
18. Aklilu F, Park M, Goltzman D, Rabbani SA. Induction of parathyroid hormone-related peptide by the Ras oncogenes: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy. Cancer Res 1997; 57: 4517-22.
19. Ball NJ, Yohn JJ, Morelli JG et al. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994; 102: 285-90.
20. Bucht E, Rong H, Pernow Y et al. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia. Cancer Res 1998; 58: 4113-16.
21. Kukreja SC, Shemerdiak WP, Lad TE, Johnson PA. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab 1980; 51: 167-9.
22. Werkmeister JR, Merryman JI, McCauley LK et al. Parathyroid hormone-related protein production by normal human keratinocytes in vitro. Exp Cell Res 1993; 208: 68-74.
23. Blomme EAG, Zhou H, Kartsogiannis V et al. Spatial and temporal expression of parathyroid hormone-related protein during wound healing. J Invest Dermatol 1999; 112: 788-95.
24. Hayman JA, Dunks JA, Ebeling PR et al. Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages. J Pathol 1989; 158: 293-6.
25. Atillasoy EJ, Burtis WJ, Milstone LM. Immunohistochemical localization of parathyroid hormone-related protein (PTHRP) in normal human skin. J Invest Dermatol 1991; 96: 277-80.
26. Michigami T, Yamato H. Mushiake S et al. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related hormone. J Clin Endocrinol Metab 1996; 81: 1090-5.
27. Rizzoli R, Feyen JH, Grau G et al. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol 1994; 143: 333-41.
28. Otsuki T, Yamada O, Kurebayashi J et al. Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells. Leukemia Lymphoma 2001; 41: 397-409.
29. Kaiser SM, Laneuville P, Bernier SM et al. Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J Biol Chem 1992; 267: 13623-8.
30. Holick MF, Ray S, Chen TC et al. A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. Proc Natl Acad Sci USA 1994; 91: 8014-16.